GLP-1 Muscle Preservation: The Protein & Training Guide for Men

The most common concern men have about GLP-1 medications isn't the nausea or the injections — it's losing muscle. And it's a legitimate concern. Pivotal trials show that roughly 25–40% of total weight lost on GLP-1 therapy comes from lean mass rather than fat. That's a real number, and ignoring it is a mistake.

But here's what the fear-driven headlines leave out: this ratio is modifiable. With the right protein intake and resistance training protocol, men on GLP-1 medications can dramatically shift the composition of their weight loss toward fat and away from muscle. The evidence is clear on how to do this.

The Baseline: What Happens Without Intervention

In the SURMOUNT-1 trial (tirzepatide for obesity), a DXA sub-analysis of participants showed approximately 10.9% loss of lean mass over 72 weeks of treatment. To put that in perspective, that approximates the average decline in muscle mass during 20 years of normal aging in adults over 30.

The STEP-1 trial (semaglutide 2.4mg) showed similar proportions — roughly 30–40% of weight lost was lean tissue in participants who did not follow specific muscle-preservation protocols.

However, a March 2026 study published in Cell Reports Medicine added important nuance: researchers found that GLP-1 medications did not cause disproportionate muscle loss compared to equivalent caloric restriction without medication. The muscle loss is a function of the caloric deficit, not the drug itself — which means the same strategies that protect muscle during any diet apply here, possibly even more so.

The BELIEVE Trial: Proof the Ratio Can Be Changed

The Phase 2b BELIEVE trial, presented at the ADA Scientific Sessions in June 2025, tested bimagrumab (a muscle-preserving antibody that blocks activin type II receptors) in combination with semaglutide. The results were striking:

Bimagrumab isn't available yet — Eli Lilly acquired it for up to $1.9 billion, and a tirzepatide combination trial is underway. But the BELIEVE trial proves a critical principle: the lean-mass-to-fat-mass ratio of weight loss is not fixed. It can be shifted dramatically with the right intervention.

For men right now, the accessible interventions are protein and resistance training. They won't deliver bimagrumab-level preservation, but the evidence shows they make a substantial difference.

Protein: The Non-Negotiable Foundation

How much you need

The research consensus for muscle preservation during weight loss on GLP-1 medications points to a minimum of 1.2 grams of protein per kilogram of body weight per day, with optimal results closer to 1.4–1.6 g/kg/day for men engaged in resistance training.

A 2025 Medscape-covered study of 200 adults who followed high-protein diets (above 1.2g/kg/day) combined with resistance training while on GLP-1 therapy achieved approximately 13% total body weight loss with only about 3% muscle mass loss — a dramatically better ratio than the uncontrolled trial data.

Timing matters: the breakfast problem

GLP-1 medications suppress appetite most strongly in the morning and early afternoon. Many men report skipping breakfast entirely or eating very little before noon. This creates a prolonged overnight fasting window that accelerates muscle protein breakdown.

The fix: prioritize protein at breakfast, even when you're not hungry. This doesn't need to be a large meal. Practical options that deliver 25–40g of protein in a low-volume format:

• Greek yogurt (plain, full-fat) — 200g delivers ~20g protein. Add a scoop of protein powder to reach 40g+
• Protein shake — whey or casein, mixed with water. 1–2 scoops. Fast, low-volume, easy on a suppressed stomach
• Eggs — 3 whole eggs = ~18g protein. Add egg whites to push higher
• Cottage cheese — 1 cup = ~28g protein. High in casein, which digests slowly

The goal is to break the overnight fast with protein as early as practical. If solid food triggers nausea in the morning (common in the first 4–6 weeks of treatment), a protein shake is the most reliable workaround.

Distribution across the day

Muscle protein synthesis is maximized when protein is distributed across 3–4 meals rather than loaded into a single sitting. The body can only utilize roughly 25–40 grams of protein per meal for muscle-building purposes (the exact threshold depends on body size and training status). Eating 120g of protein at dinner and nothing the rest of the day is significantly less effective than splitting that same amount across three meals.

Resistance Training: The Other Half

Minimum effective dose

The American College of Sports Medicine recommends resistance training that targets all major muscle groups on 2 or more days per week. For men on GLP-1 medications, 2–3 sessions per week of structured resistance training appears sufficient to substantially preserve lean mass during weight loss.

This doesn't need to be complicated. A program built around compound movements that work multiple muscle groups simultaneously delivers the strongest muscle-preservation signal:

The minimum viable program

Sets and reps: 3–4 sets of 8–12 reps per exercise, with a weight that brings you within 2–3 reps of failure. Progressive overload — gradually increasing weight, reps, or sets over time — is the driver of muscle retention.

Managing energy during training

Reduced caloric intake on GLP-1 medications can affect workout performance. Practical adjustments:

• Time workouts 2–3 hours after your largest meal to ensure available energy
• Accept that absolute strength may temporarily decrease during the weight-loss phase — the goal is retention, not personal records
• Prioritize compound movements over isolation work when energy is limited — they recruit more muscle per exercise
• Stay hydrated — GLP-1 medications can reduce thirst signals alongside appetite. Track water intake deliberately

Supplements: What's Worth Considering

Beyond protein powder (which is technically a food, not a supplement), the evidence supports a few additions for men on GLP-1 therapy:

• Creatine monohydrate (3–5g/day) — the most studied performance supplement in existence. Supports muscle retention, strength, and recovery. Inexpensive, well-tolerated, no known interactions with GLP-1 medications
• Vitamin D (if deficient) — common in men with obesity and relevant to testosterone production. Get tested before supplementing
• Electrolytes — reduced food intake can mean reduced mineral intake. A basic electrolyte supplement (sodium, potassium, magnesium) can help with fatigue and muscle cramps

What's Coming: The Pipeline

The BELIEVE trial's bimagrumab is the farthest-along muscle-preservation drug being studied in combination with GLP-1 therapy. The EMBRAZE trial (apitegromab + tirzepatide) also showed promising Phase 2 results in June 2025, preserving approximately 55% more lean mass compared to tirzepatide alone.

These combination therapies may eventually make muscle loss during GLP-1 treatment a solved problem. But they're still in clinical development. For now, protein intake above 1.2g/kg/day and 2–3 weekly resistance training sessions are the evidence-backed tools available to every man starting treatment today.